- Home
- BROS vs LNTH Comparison
BROS vs LNTH Comparison
Compare BROS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BROS
- LNTH
- Stock Information
- Founded
- BROS 1992
- LNTH 1956
- Country
- BROS United States
- LNTH United States
- Employees
- BROS N/A
- LNTH N/A
- Industry
- BROS Restaurants
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BROS Consumer Discretionary
- LNTH Health Care
- Exchange
- BROS Nasdaq
- LNTH Nasdaq
- Market Cap
- BROS 7.6B
- LNTH 7.5B
- IPO Year
- BROS 2021
- LNTH 2015
- Fundamental
- Price
- BROS $71.90
- LNTH $78.81
- Analyst Decision
- BROS Strong Buy
- LNTH Strong Buy
- Analyst Count
- BROS 15
- LNTH 5
- Target Price
- BROS $78.27
- LNTH $133.80
- AVG Volume (30 Days)
- BROS 2.8M
- LNTH 1.3M
- Earning Date
- BROS 05-07-2025
- LNTH 05-07-2025
- Dividend Yield
- BROS N/A
- LNTH N/A
- EPS Growth
- BROS 109.32
- LNTH N/A
- EPS
- BROS 0.38
- LNTH 3.53
- Revenue
- BROS $1,361,068,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- BROS $26.31
- LNTH $5.81
- Revenue Next Year
- BROS $23.86
- LNTH $12.26
- P/E Ratio
- BROS $187.12
- LNTH $22.33
- Revenue Growth
- BROS 30.42
- LNTH 12.53
- 52 Week Low
- BROS $26.96
- LNTH $74.34
- 52 Week High
- BROS $86.88
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- BROS 68.71
- LNTH 27.83
- Support Level
- BROS $58.20
- LNTH $78.61
- Resistance Level
- BROS $65.14
- LNTH $83.60
- Average True Range (ATR)
- BROS 2.66
- LNTH 3.82
- MACD
- BROS 1.44
- LNTH -2.99
- Stochastic Oscillator
- BROS 99.68
- LNTH 5.64
About BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.